15.11.2012 Views

Medicinal Plants Classification Biosynthesis and ... - Index of

Medicinal Plants Classification Biosynthesis and ... - Index of

Medicinal Plants Classification Biosynthesis and ... - Index of

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Gastroprotective Triterpenoids: Pharmacological Mechanism<br />

to yield PGH2 [31]. The latter is a relatively unstable compound that has a half-life <strong>of</strong> seconds<br />

<strong>and</strong> is a common intermediate that is converted to biologically active products such as<br />

thromboxane (TXA2), prostacyclin (PGI2), PGD2, PGE2 <strong>and</strong> PGF1α, by thromboxane<br />

synthase, prostacyclin synthase, PGD2 isomerase, PGE2 isomerase <strong>and</strong> PGF reductase<br />

respectively. The synthesis <strong>of</strong> each kind <strong>of</strong> prostagl<strong>and</strong>in depends <strong>of</strong> the cell <strong>and</strong> enzyme<br />

present in each tissue.<br />

In gastric tissue, mainly are synthesized PGE2 <strong>and</strong> PGI2. Prostagl<strong>and</strong>ins derived from<br />

COX-1 in gastric mucosa mediate many <strong>of</strong> the components <strong>of</strong> gastric mucosa defense, such<br />

as the maintenance <strong>of</strong> gastric blood flow by PGI2 <strong>and</strong> bicarbonate <strong>and</strong> mucus secretion by<br />

PGE2; in addition it retards the ability <strong>of</strong> acid <strong>and</strong> pepsin to penetrate mucus [22, 32]. When<br />

COX-1 is inhibited, COX-2 expression is induced to protect or heal gastric damage. COX-2<br />

synthesizes PGs from arachidonic acid <strong>and</strong> their functions in gastric mucosa healing are due<br />

to the inhibition <strong>of</strong> leukocyte adherence <strong>and</strong> the increment on epithelial proliferation [32].<br />

Prostagl<strong>and</strong>ins generally act in an autocrine or paracrine manner <strong>and</strong> have short half-lives<br />

(seconds to minutes) in the circulation.<br />

COX-1 is the predominant form expressed in the normal gastrointestinal tract, but COX-<br />

2 can be detected <strong>and</strong> has been shown to be rapidly up-regulated in response to a number <strong>of</strong><br />

stimuli, such as aspirin or indomethacin administration [33].<br />

Besides, COX-1 <strong>and</strong> COX-2 inhibition is required for the development <strong>of</strong> gastric<br />

erosions after NSAID administration [34, 35]. It has been reported that SC-560, a COX-1<br />

selective inhibitor, did not elicit gastric damage, even SC-560 decreased gastric blood flow<br />

<strong>and</strong> did not increase leukocyte adherence in mesentery. Furthermore, celecoxib, a selective<br />

COX-2 inhibitor, did not induce gastric damage by itself. However, celecoxib increase<br />

leukocyte adherence, while did not produce any significant changes in gastric blood flow.<br />

Celecoxib <strong>and</strong> SC-560 administered concomitantly induced a decreased on gastric blood flow<br />

<strong>and</strong> an augmented leukocyte adherence, <strong>and</strong> then this combination produced gastric erosions<br />

[35].<br />

Moreover, mice in which the gene for COX-1 was disrupted did not exhibit spontaneous<br />

gastric damage despite negligible gastric PG synthesis. However, these mice did developed<br />

erosions when indomethacin was given (a dual COX-1/COX-2 inhibitor) [34].<br />

Furthermore about mucosal defense role <strong>of</strong> COX-2, this enzyme derived prostagl<strong>and</strong>ins<br />

also make an important contribution to the repair <strong>of</strong> ulcers. COX-2 is strongly expressed in<br />

cells at the ulcer margin, which is where epithelial proliferation primarily occurs, allowing<br />

for reestablishment <strong>of</strong> gl<strong>and</strong>s. COX-2 is also strongly expressed in endothelial cells in the<br />

ulcer bed, where is the site <strong>of</strong> new vessel growth (angiogenesis) [36].<br />

3.2.2. Nitric oxide (NO)<br />

Nitric oxide is a small molecule synthesized from the terminal guanidine nitrogen atom<br />

<strong>of</strong> L-arginine. Its synthesis is carried out by a nitric oxide synthase (NOS) through a five<br />

electron oxidation reaction using as c<strong>of</strong>actors flavin mononucleotide, flavin adenine<br />

dinucleotide, tetrahydrobiopterin <strong>and</strong> protoporphyrin IX heme. There are three different<br />

is<strong>of</strong>orms <strong>of</strong> NOS, its distributions depends on cell kind. Two <strong>of</strong> them are Ca 2+ /calmodulindependent<br />

constitutive enzymes (cNOS); neuronal (nNOS) <strong>and</strong> endothelial (eNOS). The third<br />

103

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!